Wei Zhao
Research Subjects
Wei Zhao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Hai-Xue Kuang
College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China
1 shared publication - Jian-Chao Wang
Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Kai Song
Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Meng Li
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China
1 shared publication - Weisheng Feng
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, P. R. China
1 shared publication - Xiaoke Zheng
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China
1 shared publication
Latest Publications
- Open Access
A New Ionone Glycoside and Three New Rhemaneolignans from the Roots of Rehmannia glutinosa
A new ionone glycoside, frehmaglutoside I (1), and three new rhemaneolignans A–C (2–4) were isolated from the 95% EtOH extract of the roots of Rehmannia glutinosa. Their structures were determined by extensive spectroscopic (UV, IR, HR-ESI-MS, 1D and 2D NMR) analyses. In addition, these compounds were evaluated for their protective effects on cardiocytes impaired by doxorubicin in H9c2 cells. Among them, compounds 1–3 exhibited protective effects against DOX-induced cardiotoxicity.
Open AccessA New Ionone Glycoside and Three New Rhemaneolignans from the Roots of Rehmannia glutinosa
A new ionone glycoside, frehmaglutoside I (1), and three new rhemaneolignans A–C (2–4) were isolated from the 95% EtOH extract of the roots of Rehmannia glutinosa. Their structures were determined by extensive spectroscopic (UV, IR, HR-ESI-MS, 1D and 2D NMR) analyses. In addition, these compounds were evaluated for their protective effects on cardiocytes impaired by doxorubicin in H9c2 cells. Among them, compounds 1–3 exhibited protective effects against DOX-induced cardiotoxicity.